Sheaff Brock Investment Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-101,500	Closed	-$2.73M	–	493
2019 Q1	$2.73M	Buy	101,500 +1,500	+2%	+$35K	0.37%	67
2018 Q4	$1.62M	Buy	100,000 +27,500	+38%	+$534K	0.25%	81
2018 Q3	$1.5M	Buy	72,500 +22,500	+45%	+$354K	0.19%	102
2018 Q2	$764K	Hold	50,000	–	–	0.1%	191
2018 Q1	$1.12M	Hold	50,000	–	–	0.15%	133
2017 Q4	$1.51M	Hold	50,000	–	–	0.2%	104
2017 Q3	$1.88M	Sell	50,000 -1,000	-2%	-$32.5K	0.25%	92
2017 Q2	$1.42M	Buy	51,000 +1,000	+2%	+$29.8K	0.19%	109
2017 Q1	$1.72M	Hold	50,000	–	–	0.22%	95
2016 Q4	$1.44M	Hold	50,000	–	–	0.18%	111
2016 Q3	$1.59M	Hold	50,000	–	–	0.21%	96
2016 Q2	$1.62M	Sell	50,000 -3,000	-6%	-$100K	0.21%	99
2016 Q1	$1.48M	Hold	53,000	–	–	0.18%	114
2015 Q4	$1.89M	Buy	+53,000	New	+$1.87M	0.21%	113